EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cavitary retinoblastoma: Clinical features and treatment outcomes

Nakul Verma, Rohan Kapoor, Vijitha S Vempuluru, P Vijay Anand Reddy, Vishal R Raval, Swathi Kaliki

Indian Journal of Ophthalmology · 2026-06 · 74 (6) · 876-881

DOI: 10.4103/ijo.ijo_2146_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Ophthalmology, online erschienen am 27.05.2026. Verfasst von Nakul Verma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Anant Bajaj Retina Institute, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Retinoblastoma, Retinal Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To describe clinical characteristics and treatment outcomes of children diagnosed with cavitary retinoblastoma (RB).

Methods

Retrospective analysis of children treated for cavitary RB.

Results

Of the 40 patients (43 eyes) with cavitary RB, 14 (35%) were female and 26 (65%) were male. At diagnosis, the average age was 25 months (median, 24 months; range 3–84 months). In 3 cases (8%), bilateral cavitary RB was seen. The most prevalent presenting symptoms were leukocoria (n = 21, 53%) and strabismus (n = 6, 15%) with a mean duration of symptoms of 23 weeks (median, 16 weeks; range 0–104 weeks). As per the ICRB classification, 15 eyes (35%) were in group D, 12 eyes (28%) in group C, 10 eyes (23%) in group B, and 6 eyes (14%) in group E. Primary cavities, within the tumor, were seen in 14 eyes (33%), whereas secondary cavities were seen in 29 eyes (67%). Most of the eyes (n = 42, 98%) were treated with intravenous chemotherapy (IVC), and one eye (2%) received intra-arterial chemotherapy. In ten eyes (23%), the tumor recurred following IVC, and two cases exhibited a partial response to IVC. At the last follow-up (mean, 31 months), all eyes (100%) had local tumor control with no evidence of systemic metastasis or death. Regression of the cavities within the tumor was noted in 27 eyes (63%), while it remained stable in 16 eyes (37%).

Conclusion

Cavitary RB (both primary and secondary) had a good initial response to standard chemotherapy with an overall excellent prognosis for globe salvage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RetinoblastomaRetinal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMaleRetrospective StudiesInfantChild, PreschoolTreatment OutcomeChildFollow-Up StudiesAntineoplastic Agents

Stichwörter der Autor:innen

Cavitarycavityclinical featuresretinoblastomatreatment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Anant Bajaj Retina Institute, Hyderabad, Telangana, India.
  • The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, Telangana, India.

Zitieren

APA

Verma, N., Kapoor, R., Vempuluru, V. S., Reddy, P. V. A., Raval, V. R., & Kaliki, S. (2026). Cavitary retinoblastoma: Clinical features and treatment outcomes. Indian Journal of Ophthalmology, 74(6), 876-881. https://doi.org/10.4103/ijo.ijo_2146_25

Vancouver

Verma N, Kapoor R, Vempuluru VS, Reddy PVA, Raval VR, Kaliki S. Cavitary retinoblastoma: Clinical features and treatment outcomes. Indian Journal of Ophthalmology. 2026;74(6):876-881. doi:10.4103/ijo.ijo_2146_25

BibTeX
@article{Verma2026,
  author = {Verma, Nakul and Kapoor, Rohan and Vempuluru, Vijitha S and Reddy, P Vijay Anand and Raval, Vishal R and Kaliki, Swathi},
  title = {Cavitary retinoblastoma: Clinical features and treatment outcomes},
  journal = {Indian Journal of Ophthalmology},
  year = {2026},
  volume = {74},
  number = {6},
  pages = {876--881},
  doi = {10.4103/ijo.ijo_2146_25}
}
Kostenlos starten →